A carregar...
A rare case of imatinib-induced erythroderma
Imatinib, a specific tyrosine kinase inhibitor is a newer anticancer agent, which has shown excellent efficacy in managing chronic myeloid leukemia. It is generally well tolerated with few side effects. Most commonly reported adverse events are maculopapular eruptions and periorbital edema. Severe a...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications & Media Pvt Ltd
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3847261/ https://ncbi.nlm.nih.gov/pubmed/24347779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.121386 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|